It is anticipated that the initial capitalization of € 15.0 million , adding at least 25 percent in outright subsidies, will lead us to a sales level of some two million handgun retrofits (of the 210 million world handgun market) within four years for an estimated $300 million in gross revenues, and a net profit of $60 million annually for the Foundation, with a similar revenue stream from the profit side of Biomac for their enrollment operation as well other applications of the technology to access control new weapon sales.
The most lucrative end of Biomac’s revenue stream in weapon access control will come should they dominate the market in smart gun technology, thereby reaping their greatest profits from reprogramming of existing biometric weapons, and/or warrantee maintenance.